MNOV
MediciNova Inc
NASDAQ: MNOV · HEALTHCARE · BIOTECHNOLOGY
$1.37
+0.74% today
Updated 2026-04-29
Market cap
$67.43M
P/E ratio
—
P/S ratio
164.61x
EPS (TTM)
$-0.24
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
MediciNova Inc (MNOV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,038.00%
ROE
-25.50%
ROA
-16.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $263877.00 | $-35.69M | 44.44% | -15,794.30% | -13,525.09% |
| 2007 | $263.88M | $-48.90M | 44.44% | -20.27% | -18.53% |
| 2008 | — | $-21.92M | — | — | — |
| 2009 | — | $-20.37M | — | — | — |
| 2010 | — | $-20.19M | — | — | — |
| 2011 | $0.00 | $-17.73M | — | — | — |
| 2012 | $802580.00 | $-10.96M | 100.00% | -1,363.77% | -1,365.76% |
| 2013 | $6.00M | $-4.03M | 100.00% | -66.97% | -67.11% |
| 2014 | $0.00 | $-9.20M | — | — | — |
| 2015 | $0.00 | $-8.85M | — | — | — |
| 2016 | $0.00 | $-10.87M | — | — | — |
| 2017 | $0.00 | $-11.16M | — | — | — |
| 2018 | $0.00 | $-14.68M | — | — | — |
| 2019 | $0.00 | $-12.94M | — | — | — |
| 2020 | $4.00M | $-13.85M | -0.53% | -354.46% | -346.35% |
| 2021 | $4.04M | $-10.13M | 100.00% | -253.02% | -251.00% |
| 2022 | $0.00 | $-14.07M | — | — | — |
| 2023 | $1.00M | $-8.57M | 100.00% | -990.03% | -857.15% |
| 2024 | $0.00 | $-11.05M | — | — | — |
| 2025 | $409657.00 | $-12.00M | 7.58% | -3,242.47% | -2,928.78% |